Total Raised

$2.25M

Investors Count

1

Funding, Valuation & Revenue

2 Fundings

Vala Sciences has raised $2.25M over 2 rounds.

Vala Sciences's latest funding round was a Loan for $0.25M on April 10, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/10/2020

Loan

$0.25M

$XXM

0

FY undefined

9/29/2015

Unattributed

$XXM

$XXM

0

FY undefined

10

Date

4/10/2020

9/29/2015

Round

Loan

Unattributed

Amount

$0.25M

$XXM

Investors

Valuation

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

Sources

10

Start free trial
New call-to-action

Vala Sciences Investors

1 Investors

Vala Sciences has 1 investors. Paycheck Protection Program invested in Vala Sciences's Loan funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/10/2020

4/10/2020

1
Loan

Government

DC

First funding

4/10/2020

Last Funding

4/10/2020

Investor

Rounds

1
Loan

Board Seats

Type

Government

Location

DC

New call-to-action

Compare Vala Sciences to Competitors

A
Alera Labs

Alera Labs is a contract analytical testing laboratory that provides analytical and pre-formulation support for the pharmaceutical, biotech, medical device, and agricultural sectors. The company offers services including the development of analytical methods, structure elucidation of degradation products and impurities, bioanalytical testing, method validation, and developmental stability studies. Alera Labs serves small startup companies. It was founded in 2010 and is based in Durham, North Carolina.

C
Concept Life Sciences

Concept Life Sciences provides drug development services in scientific disciplines including chemistry, biology, and toxicology. The company offers services such as drug discovery, medicinal chemistry, biology studies, and toxicology assessments to assist in the development of therapies. Concept Life Sciences serves sectors in need of drug development and safety assessment, including areas like oncology, neuroscience, and immunology. It was founded in 2014 and is based in Sandwich, United Kingdom.

S
Syenta

Syenta focuses on metallization for advanced packaging and electronics within the semiconductor industry. It provides manufacturing products that facilitate the production of semiconductor chips, utilizing a localized electrochemical method. Its technology integrates patterning and metallization processes into a single tool. It was founded in 2022 and is based in Everleigh, Australia.

Sartorius Logo
Sartorius

Sartorius focuses in life sciences research and biopharmaceutical manufacturing, providing laboratory instruments and consumables. The company supplies solutions for drug discovery, development, and production platforms for biomanufacturing, with an emphasis on single-use products for bioprocessing. Sartorius serves pharmaceutical and biopharmaceutical companies, as well as academic research institutions. It was founded in 1870 and is based in Goettingen, Germany.

Avacta Therapeutics Logo
Avacta Therapeutics

Avacta Therapeutics is a biotechnology company focused on developing cancer treatments within the healthcare sector. The company specializes in a drug delivery platform that activates cancer drugs at the tumor site, utilizing technology that links peptides to existing cancer drugs, which are inactivated until they reach the tumor. Avacta Therapeutics serves the healthcare and pharmaceutical industries with its research and development of therapeutics and diagnostics. It was founded in 2012 and is based in London, United Kingdom.

Sepax Technologies Logo
Sepax Technologies

Sepax Technologies provides chromatography products and services within the biological separation industry. It offers High-Performance Liquid Chromatography (HPLC) columns for bioanalytical characterization and testing, as well as process media for downstream processing and purification of biologics, including monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, proteins, viral vectors, and nucleic acids. It serves the biopharmaceutical industry with bead technology platforms and support for various stages of research and development and production pipelines. It was founded in 2002 and is based in Suzhou, China.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.